YIH
PNT

Y-Intercept (HK)’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Y-Intercept (HK)’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,568
Closed -$140K – 1275
2022
Q1 		$140K Buy
+17,568
New +$112K 0.03% 649

Other funds holding PNT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Y-Intercept (HK)'s PNT Position: Q2 2022 in Review

Y-Intercept (HK) sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q2 2022, closing a stake of 17,568 shares — an estimated $140K sold.

Y-Intercept (HK) first reported a position in PNT in Q1 2022 and held it in 1 quarter. The position peaked at $140K in Q1 2022. 84 funds tracked by Wall St. Rank hold PNT as of Q2 2022.

  • Y-Intercept (HK) reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Y-Intercept (HK) sold 17,568 POINT Biopharma Global Inc. Common Stock shares in Q2 2022, an estimated $140K.
  • Y-Intercept (HK) first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Y-Intercept (HK)'s POINT Biopharma Global Inc. Common Stock position peaked at $140K in Q1 2022.
  • 84 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q2 2022.

Based on Y-Intercept (HK)'s 13F filing for Q2 2022, filed 8 Aug 2022.